Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-13 1:21 pm Sale | 2024-09-30 | 13G | Agile Therapeutics, Inc. AGRX | Beryl Capital Management LLC | 0 0.000% | -680,000 (Position Closed) | Filing History |
| 2024-08-26 4:47 pm Purchase | 2024-08-06 | 13G | Agile Therapeutics, Inc. AGRX | Mastrangeli Doug | 350,000 5.100% | 350,000 (New Position) | Filing History |
| 2024-07-22 4:50 pm Purchase | 2024-07-10 | 13G | Agile Therapeutics, Inc. AGRX | TANG CAPITAL PARTNERS LP | 426,153 6.200% | 426,153 (New Position) | Filing History |
| 2024-07-09 2:20 pm Purchase | 2024-06-26 | 13G | Agile Therapeutics, Inc. AGRX | Beryl Capital Management LLC | 680,000 9.900% | 680,000 (New Position) | Filing History |
| 2024-07-02 3:44 pm Purchase | 2024-06-26 | 13G | Agile Therapeutics, Inc. AGRX | Klein Roger M. | 618,000 9.000% | 618,000 (New Position) | Filing History |
| 2024-02-13 8:02 pm Purchase | 2023-12-31 | 13G | Agile Therapeutics, Inc. AGRX | Lind Global Fund II LP | 44,750 1.800% | 44,750 (New Position) | Filing History |
| 2024-02-06 10:14 am Purchase | 2023-12-31 | 13G | Agile Therapeutics, Inc. AGRX | Mitchell P. Kopin | 23,961 0.900% | 23,961 (New Position) | Filing History |
| 2023-02-14 2:31 pm Unchanged | 2022-12-31 | 13G | Agile Therapeutics, Inc. AGRX | Perceptive Advisors LLC | 0 0.000% | 0 (Unchanged) | Filing History |
| 2023-02-13 4:33 pm Purchase | 2022-12-31 | 13G | Agile Therapeutics, Inc. AGRX | Lind Global Fund II LP | 89,195 9.900% | 24,191 (+37.21%) | Filing History |
| 2023-02-08 06:06 am Sale | 2022-12-31 | 13G | Agile Therapeutics, Inc. AGRX | Mitchell P. Kopin | 54,600 6.300% | -14,007 (-20.42%) | Filing History |
| 2022-07-12 5:00 pm Purchase | 2022-07-06 | 13G | Agile Therapeutics, Inc. AGRX | Lind Global Fund II LP | 65,004 9.900% | 65,004 (New Position) | Filing History |
| 2022-07-11 06:06 am Purchase | 2022-07-01 | 13G | Agile Therapeutics, Inc. AGRX | Mitchell P. Kopin | 68,607 9.990% | 68,607 (New Position) | Filing History |
| 2022-02-14 3:57 pm Purchase | 2021-12-31 | 13G | Agile Therapeutics, Inc. AGRX | Perceptive Advisors LLC | 10,647 17.500% | 2,687 (+33.76%) | Filing History |
| 2022-02-09 3:16 pm Purchase | 2021-12-31 | 13G | Agile Therapeutics, Inc. AGRX | The Vanguard Group | 2,247 3.700% | 61 (+2.79%) | Filing History |
| 2021-07-12 08:29 am Sale | 2021-06-30 | 13G | Agile Therapeutics, Inc. AGRX | BlackRock Inc. BLK | 654 1.500% | -1,907 (-74.45%) | Filing History |